We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Merck, Glenmark Stifled Cholesterol Drug Market, Suit Says

Law360, Los Angeles (January 17, 2018, 9:05 PM EST) -- Merck & Co. and generics manufacturer Glenmark Pharmaceuticals Inc. were hit with a putative class action in Virginia federal court Wednesday claiming an agreement to keep a generic version of cholesterol...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.